Rocky Mountain REACH (RMT-REACH)

落基山 REACH (RMT-REACH)

• 批准号: 10783596
• 负责人: Karen Brown
• 金额: $ 100万
• 依托单位: UNIVERSITY OF MONTANA
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-25 至 2027-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10783596
• 关键词: Academia; Academic support; Acceleration; Address; Alaska; Area; Biological Sciences; Biomedical Research; Businesses; Clinical; Collaborations; Communities; Development; Devices; Diagnostic; Economic Development; Ecosystem; Ensure; Entrepreneurship; Equity; Evaluation Research; Fostering; Funding; Geography; Goals; Growth; Health; Health Personnel; Health system; Human; Idaho; Industry; Infrastructure; Institution; Investments; Leadership; Legal; Life Cycle Stages; Location; Marketing; Medical; Medical Device; Mentors; Minority; Modeling; Montana; Pathway interactions; Persons; Pharmaceutical Preparations; Positioning Attribute; Recording of previous events; Research; Research Personnel; Resource Allocation; Resource-limited setting; Resources; Rural; Rural Community; System; Technology; Therapeutic; Training; Translations; Tribes; United States; United States National Institutes of Health; Universities; Washington; Woman; Wyoming; burden of illness; college; commercialization; community college; design; experience; health disparity; health disparity populations; innovation; medically underserved population; metropolitan; mortality; next generation; novel diagnostics; product development; programs; prototype; research and development; success; technical college; tribal college; tribal community; tribal institution; undergraduate student; underserved community

PROJECT SUMMARY/ABSTRACT The L.S. Skaggs Institute for Health Innovation (SIHI)-Research Evaluation and Commercialization Hub (SIHI- REACH) at the University of Montana (UM) will catalyze the emerging biomedical industry corridor in Montana and the surrounding states by establishing a hub to accelerate translation of academic discoveries into products that impact human health. Untapped opportunities exist in IDeA states to turn biomedical research discoveries into technologies that address unmet medical needs, disease burden, and health disparities for populations across the United States (US). We have partnered with 10 academic institutions across the IDeA states in the Washington, Wyoming, Alaska, Montana, and Idaho (WWAMI) region—including a community, a technological, and a tribal college—as well as the Washington Entrepreneurial-REACH (WE-REACH) at the University of Washington to gain invaluable guidance from their leadership team. Academic discovery is indispensable for ensuring a pipeline of research for novel diagnostics, devices, and therapies, yet sustainable infrastructure to support academic innovators in resource-limited regions has yet to be fully realized. Geographically remote regions have unique challenges in developing and promoting commercialization and entrepreneurship, including lack of infrastructure, less access to innovators and subject matters experts, and lower levels of funding. Gaps in resource allocation contribute to higher rates of mortality and disease burden, and health systems in these areas have traditionally been late to implement health innovation when compared to their metropolitan counterparts. In order for health innovation to reach clinical usefulness for all people, efforts are needed to ensure the inclusion of minority, geographically-isolated, and historically medically underserved populations at every stage of the biomedical research life cycle. We will accomplish our ultimate goals through the following aims: 1) Identify emerging biomedical discoveries with commercial viability in academic institutions within the four regional IDeA states supported by SIHI-REACH, emphasizing discoveries that address disease burden and health disparities for underserved communities; 2) Develop an innovative implementation system to enable access to gap funding, key subject matter experts in areas of product development, regulatory, reimbursement, legal, business development, and overall commercial strategy for academic researchers in resource-limited areas; 3) Provide funding and project management support for promising technologies and development teams to accelerate product definition studies; and 4) Elevate a WWAMI region-wide pro-entrepreneurial culture among academic investigators by engaging and mentoring biomedical innovators in rural and tribal institutions. With a strong leadership team providing diverse and complementary expertise and proven experience in entrepreneurial startups, SIHI-REACH will train the next generation of biomedical innovators in entrepreneurship and product development, positively impact the regional economy, and bring products that address health disparities to market. 1

项目总结/摘要 LS Skaggs健康创新研究所（SIHI）-研究评估和商业化中心（SIHI）- REACH）将促进蒙大拿州新兴的生物医学产业走廊 通过建立一个中心，加速将学术发现转化为 影响人类健康的产品。IDEA州存在未利用的机会，可以将生物医学研究 将发现转化为技术，解决未满足的医疗需求、疾病负担和健康差距， 美国各地的人口（US）。我们与IDEA的10个学术机构合作 华盛顿、怀俄明州、阿拉斯加、蒙大拿和爱达荷州（WWAMI）地区的州-包括社区、 技术，和部落学院，以及华盛顿创业REACH（WE-REACH）在 华盛顿大学获得他们的领导团队的宝贵指导。学术发现是 对于确保新型诊断、设备和疗法的研究管道不可或缺，但可持续 支持资源有限地区学术创新者的基础设施尚未完全实现。 地理位置偏远的区域在发展和促进商业化方面面临独特的挑战， 创业，包括缺乏基础设施，更少地接触创新者和主题专家， 资金水平较低。资源分配方面的差距导致死亡率和疾病负担上升， 这些地区的卫生系统传统上实施卫生创新的时间较晚， 大都市的同行为了使卫生创新达到对所有人的临床实用性， 需要努力确保少数民族、地理上孤立的人和历史上在医学上 在生物医学研究生命周期的每一个阶段，都需要为得不到充分服务的人群提供服务。我们将完成我们的终极目标 通过以下目标实现目标：1）确定具有商业可行性的新兴生物医学发现， SIHI-REACH支持的四个区域IDEA州内的学术机构，强调发现 解决服务不足社区的疾病负担和健康差距; 2）制定创新的 实施系统，以便能够获得差距资金，产品领域的关键主题专家 开发、监管、报销、法律的、业务开发和整体商业战略， 资源有限地区的学术研究人员; 3）提供资金和项目管理支持， 有前途的技术和开发团队，以加快产品定义研究;以及4）提升 WWAMI通过参与和指导，在学术研究人员中形成区域范围的亲创业文化 农村和部落机构的生物医学创新者。凭借强大的领导团队， SIHI-REACH将通过专业知识和在创业型初创公司的成熟经验， 在创业和产品开发中产生生物医学创新者， 区域经济，并将解决健康差距的产品推向市场。 1